Asad, Sarah
Damicis, Adrienne
Heng, Yujing J.
Kananen, Kathryn
Collier, Katharine A.
Adams, Elizabeth J.
Kensler, Kevin H.
Baker, Gabrielle M.
Wesolowski, Robert
Sardesai, Sagar
Gatti-Mays, Margaret
Ramaswamy, Bhuvaneswari
Eliassen, A. Heather
Hankinson, Susan E.
Tabung, Fred K.
Tamimi, Rulla M.
Stover, Daniel G.
Funding for this research was provided by:
National Institutes of Health, United States (R01 CA260352, R01 CA260352, R01 CA260352, R01 CA260352, R01 CA260352)
Conquer Cancer Foundation
National Institutes of Health (U01 CA176726, U01 CA176726, U01 CA176726, L30 CA189226)
Spielman Fund for Cancer Research
Article History
Received: 26 April 2022
Accepted: 1 November 2022
First Online: 14 November 2022
Declarations
:
: The study protocol was approved by the institutional review boards of the Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required. All participants provided written consent.
: The manuscript and code were approved by Channing Review.
: The authors have no conflicts of interest to report.